Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cellebrite DI (CLBT) Current Assets (2020 - 2025)

Cellebrite DI's Current Assets history spans 6 years, with the latest figure at $575.8 million for Q4 2025.

  • Quarterly Current Assets rose 1.45% to $575.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $575.8 million through Dec 2025, up 1.45% year-over-year, with the annual reading at $575.8 million for FY2025, 1.45% up from the prior year.
  • Current Assets came in at $575.8 million for Q4 2025, down from $668.4 million in the prior quarter.
  • In the past five years, Current Assets ranged from a high of $668.4 million in Q3 2025 to a low of $233.6 million in Q2 2022.
  • The 5-year median for Current Assets is $376.2 million (2023), against an average of $403.7 million.
  • Year-over-year, Current Assets decreased 15.75% in 2021 and then skyrocketed 46.14% in 2025.
  • Cellebrite DI's Current Assets stood at $273.2 million in 2021, then rose by 8.32% to $295.9 million in 2022, then surged by 42.63% to $422.1 million in 2023, then surged by 34.47% to $567.6 million in 2024, then grew by 1.45% to $575.8 million in 2025.
  • Per Business Quant, the three most recent readings for CLBT's Current Assets are $575.8 million (Q4 2025), $668.4 million (Q3 2025), and $606.1 million (Q2 2025).